NCT01143298

LEO 27847 - Single Dose Bioavailability Study of Oral Solution Versus Tablet in Healthy Subjects

LEO 27847 - A Single Dose Bioavailability Study of Oral Solid Dosage Form Versus Oral Solution Including Fed Versus Fasted State in Healthy Male Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: LEO Pharma · Industry
• Sex: Male
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The purpose of this phase 1 study is to determine the relative bioavailability following single oral dose administration of LEO 27847 solution compared to LEO 27847 tablets in healthy male subjects as well as to determine the effect of food on the single oral dose pharmacokinetics of LEO 27847 tablets in healthy male subjects.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	LEO 27847 oral solution

Timeline

• Start date: 2010-06-01
• Primary completion: 2010-08-01
• Completion: 2010-09-01
• First posted: 2010-06-14
• Last updated: 2025-02-24

Locations

1 site across 1 country: United Kingdom